Investors

Cambridge Innovation Capital plc (CIC) combines a unique relationship with the University of Cambridge with deep financial and industry links to invest in rapidly growing intellectual property rich companies in the Cambridge Cluster. CIC has an unrivalled appreciation for the application of world-leading scientific developments given its position within the Cambridge Cluster. The company is committed to building leading businesses from brilliant technologies – with the support of some of the most influential figures in the sector and a patient capital structure. For further information, including more details of CIC portfolio companies, see: www.cicplc.co.uk

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck’s core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck’s science and technology base. Find out more at: www.merck-ventures.com

Pfizer Venture Investments (PVI), the venture capital arm of Pfizer Inc, was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. As part of worldwide business development, PVI seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing compounds and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry. Find out more here.

Touchstone Innovations, formerly known as Imperial Innovations, creates, builds and invests in pioneering technologies addressing global problems in healthcare, energy, engineering and the environment. It combines deep understanding of science and technology with commercial acumen and strong investment expertise, and supports scientist-entrepreneurs in the commercialisation of their ideas. In December 2010 Touchstone Innovations raised £140 million to accelerate the making of, and increase the size of, investments in companies established under its existing intellectual property pipeline agreement with Imperial College London. The group also invests in companies founded by or based on technology from the University of Oxford, the University of Cambridge and University College London. Find out more at: www.touchstoneinnovations.com

Find out more about our: